|
FDA批准首例治疗遗传性罕见病的疗法
2019.11.20
For Immediate Release November 20, 2019
Today, the U.S. Food and Drug Administration granted approval to Givlaari (givosiran) for the treatment of adult patients with acute hepatic porphyria【FDA批准Givosiran治疗急性肝卟啉症】, a genetic disorder res...
|
